Glycopyrrolate Transdermal Patch 1.5mg/day from Japan
Extended-release transdermal patch delivering 1.5mg glycopyrrolate daily for hyperhidrosis and sialorrhea via skin absorption affecting digestive glands. Form of transdermal system in measured doses under HTS 3004.90.92.57.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Adhesive matrix testing for skin irritation compliance
• Controlled substance checks if analogs trigger DEA rules
• Shelf-life extension data for patches mandatory